Jeffrey W Keillor

40PUBLICATIONS
64CO-AUTHORS
Biomolecular modelling and designBiologically active moleculesProteins and peptidesHaematological tumoursCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Sep 23, 2026
Artificial Intelligence and Virtual Screening to Identify Small Molecules Inhibiting Transglutaminase 2 for Investigation and Treatment of Breast Cancer.

|Apr 30, 2026
Don't Lose Your (War)head: Structure-Activity Relationships of Covalent Warheads as Substrates for GST-Catalyzed Glutathione Conjugation.

|Nov 24, 2025
Structure-activity relationships of hydrophobic small molecule irreversible inhibitors of tissue transglutaminase.

Daniel A Wallace, Sarah Tribe, Pauline Navals

|Oct 30, 2025
Discovery of an internal alkyne warhead scaffold for irreversible hTG2 inhibition.

Lavleen K Mader, Namita Maunick, Jessica E Borean

|Jul 03, 2025
Transglutaminase 2 function in glioblastoma tumor efferocytosis.

Margarita Lui, Filiz Sevinc, Mara Elgafarawi

|Mar 31, 2025
Methods for kinetic evaluation of reversible covalent inhibitors from time-dependent IC50 data.

Lavleen K Mader, Jeffrey W Keillor

Pageof 7

Frequent Collaborators

6 joint publications

Lavleen Mader

6 joint publications

Eric W J Gates

4 joint publications

Nicoletta Bianchi

3 joint publications

Richard L Eckert